Funders join forces to support dementia research in Canada

Alzheimer's Research UK supports new Canadian Consortium for dementia research.

Posted on 10th September 2014

Alzheimer’s Research UK has provided support to a new national initiative getting underway in Canada to support research into dementia. The Canadian Consortium on Neurodegeneration in Aging (CCNA) has been launched today ahead of the Canada-France Global Legacy Event being held in Ottowa this week.

The CCNA brings together 20 research teams from across Canada to focus efforts on preventing and delaying the onset of dementia, as well as improving the lives of people already affected. The CCNA is supported by $31.5m of funding over five years from the Canadian Institutes of Health Research and 13 other partners including Alzheimer Society of Canada and Alzheimer’s Research UK. The teams will also receive a further $24m from a subset of the partners in Ontario and Quebec.

The announcement was made ahead of the Canada-France Global Legacy Event to be held in Ottawa on 11-12 September. The event brings together 200 experts from G7 countries and focuses on building global academic-industry partnerships and promoting innovation in dementia prevention, treatment and care. Promoting academic collaboration with industry is an area in which Alzheimer’s Research UK has been leading the way, with initiatives such as the Dementia Consortium and a network of Drug Discovery Institutes. Dr Eric Karran, Director of Research, and Dr Simon Ridley, Head of Research at the charity, are attending the event to share best practice from these projects with other funders across the world.

Dr Eric Karran, Director of Research at Alzheimer’s Research UK, said:

“As the leading research charity in the UK, we are delighted to continue our programme of funding the very best in international dementia research through our support of the CCNA. The consortium represents the kind of innovative public, private and philanthropic partnership that can help new ideas in research become benefits for people with dementia around the world. As G7 leaders meet in Canada, CCNA represents an exciting model for collaboration that will be of great interest to other nations.”

The Honourable Rona Ambrone, Canadian Minister of Health, said:

“Our Government is proud to be making this significant investment to face the global dementia challenge with over fourteen provincial, public and private partners. The large consortium announced today will accelerate innovative and collaborative research to make a difference in the quality of life and the quality of services for Canadians affected by these diseases. With the Canadian Consortium on Neurodegeneration in Aging, we are joining forces with our international counterparts to support additional research with a view to finding a cure for dementia by 2025.”

Posted in Fundraising news